FDA Clearance Tracker · K250588
Access Rubella IgG
Last checked: Nov 19, 2026Latest source record: Nov 17, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 17, 2025
Substantially Equivalent
Time to decision
263 days
Received Feb 27, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250588
- Device name
- Access Rubella IgG
- Applicant
- Beckman Coulter, Inc.
- Applicant location
- Chaska, MN
- Received
- Feb 27, 2025
- Decided
- Nov 17, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3510
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LFX. The earliest in FDA's data is K791746, decided Nov 16, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250588
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Beckman Coulter, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Access BNP II510(k)
K262597 · Decided Oct 20, 2026 · 85 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
- Access MeMed BV510(k)
K261109 · Decided Oct 19, 2026 · 199 days after receipt
Device type: Immunoassay For Host Biomarkers Of Infection (QPS) · Laboratory Medicine & Pathology
- Access NT-proBNP510(k)
K262109 · Decided Sep 21, 2026 · 90 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.